Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, January 4th:

ImmunoGen, Inc. : This commercial-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 250% over the last 60 days.

ImmunoGen, Inc. Price and Consensus

ImmunoGen, Inc. price-consensus-chart | ImmunoGen, Inc. Quote

ImmunoGen’s shares gained 88.4% over the last three months compared with the S&P 500’s advance of 10.7%. The company possesses a Momentum Score  of B.

ImmunoGen, Inc. Price

ImmunoGen, Inc. price | ImmunoGen, Inc. Quote

GitLab Inc. (GTLB Quick QuoteGTLB - Free Report) : This software development company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 285.71% over the last 60 days.

GitLab Inc. Price and Consensus

GitLab Inc. price-consensus-chart | GitLab Inc. Quote

Gitlab’s shares gained 31% over the last three months compared with the S&P 500’s advance of 10.7%. The company possesses a Momentum Score of B.

GitLab Inc. Price

GitLab Inc. price | GitLab Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.